Literature DB >> 15510609

Extended intestinal metaplasia. A survey of 1392 gastrectomies from dwellers of the Pacific basin.

C A Rubio1, T Hirota, M Itabashi, K Mandai, A Yanagisawa, T Kitagawa, H Sugano, Y Kato.   

Abstract

BACKGROUND: To assess the extent of gastric intestinal metaplasia (IM) in gastrectomy specimens in populations of the Pacific basin having different incidence of gastric carcinoma.
MATERIALS AND METHODS: One thousand three hundred and nine-two gastrectomies were investigated: 1088 had a gastric carcinoma and 304 miscellaneous gastric diseases. Twenty-one thousand three hundred and fourteen histological sections were reviewed under low-power (4X). IM was either spotty (SIM) or extended (EIM= encompassing one or more entire low-power fields/section). Widespread IM (WIM) was regarded as EIM if present in > or =5 histological sections. RESULTS AND
CONCLUSION: The percent of gastrectomies harboring a carcinoma increased significantly with increasing age more notably in those with diffuse carcinomas (DC) than in those with intestinal carcinomas (IC). The percent of gastrectomies with EIM was significantly higher in specimens with IC than with DC, particularly among elderly patients, and in specimens from countries with a high cancer incidence. The percent of gastrectomies with WIM was higher in specimens having IC than in those having DC. Migration per se did not influence the frequency of specimens with EIM in elderly Japanese patients: Japanese migrants to Hawaii had a similarly high frequency of EIM as those dwelling in Japan. Japanese patients with a gastric carcinoma showed atypical mitoses in areas with EIM far from the tumor, suggesting that cellular mutation(s) play a role in the evolution of EIM towards gastric dysplasia and carcinoma in that ethnic group. The drawback of gastric biopsies in assessing the extent of gastric intestinal metaplasia and, thereby, estimating possible cancer risk in long-term studies has been stressed.

Entities:  

Mesh:

Year:  2004        PMID: 15510609

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Gastric intestinal metaplasia.

Authors:  C A Rubio; R Befrits
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

2.  Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis.

Authors:  Kaushik Mukherjee; Dunfa Peng; Zaid Brifkani; Abbes Belkhiri; Manuel Pera; Tatsuki Koyama; Elizabeth A S Koehler; Frank L Revetta; Mary K Washington; Wael El-Rifai
Journal:  Surgery       Date:  2010-07-01       Impact factor: 3.982

3.  Premalignant lesions in gastric cancer.

Authors:  Kazuo Yashima; Shuji Sasaki; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2009-12-16

4.  Extensive intestinal metaplasia in gastric carcinoma and in other lesions requiring surgery: a study of 3,421 gastrectomy specimens from dwellers of the Atlantic and Pacific basins.

Authors:  C A Rubio; J Jónasson; G Nesi; K Mandai; R Pisano; A King; D Owen
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

5.  Gastric ciliated metaplasia. A study of 3406 gastrectomy specimens from dwellers of the Atlantic and the Pacific basins.

Authors:  C A Rubio; G Nesi; G C Zampi; P A de Ruiz; J Jessurun; J Jónasson; R Hojman; Z Kogan; D Antonioli; M L Miller; T Hirota; T Itabashi; K Mandai; T Kitagawa; H Sugano; Y Kato; A King; R Pisano; D Owen
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

6.  Role of p53 in the progression of gastric cancer.

Authors:  Rita A Busuttil; Giada V Zapparoli; Sue Haupt; Christina Fennell; Stephen Q Wong; Jia-Min B Pang; Elena A Takeno; Catherine Mitchell; Natasha Di Costanzo; Stephen Fox; Ygal Haupt; Alexander Dobrovic; Alex Boussioutas
Journal:  Oncotarget       Date:  2014-12-15

7.  Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race.

Authors:  Mitchell S Wachtel; Yan Zhang; Maurizio Chiriva-Internati; Eldo E Frezza
Journal:  BMC Cancer       Date:  2006-03-15       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.